Betaine (TMG) for Methylation, Homocysteine, and Longevity: Complete Evidence-Based Guide
Our Top Picks
Betaine (TMG) for Methylation, Homocysteine, and Longevity: Complete Evidence-Based Guide
Quick Summary: Betaine (trimethylglycine/TMG) is a methyl donor that lowers homocysteine by up to 20–30% in clinical trials, supports liver fat metabolism, and may extend lifespan via methylation pathway optimization. Typical dose: 1,500–3,000 mg daily. Best forms: anhydrous betaine (pure TMG) or betaine HCl (for low stomach acid).
What Is Betaine (Trimethylglycine)?
Betaine, also known as trimethylglycine (TMG), is a naturally occurring compound first isolated from sugar beets (Beta vulgaris) — hence the name. It functions as an osmolyte (protecting cells from osmotic stress) and, critically, as a methyl donor in the methionine cycle.
Key Biochemical Role
Homocysteine + Betaine → Methionine + Dimethylglycine
(via BHMT enzyme)
This reaction, catalyzed by betaine-homocysteine methyltransferase (BHMT), is the only alternative pathway to remethylate homocysteine to methionine besides the folate/B12-dependent methionine synthase route. This makes betaine uniquely valuable for individuals with MTHFR polymorphisms or B-vitamin deficiencies.
Evidence-Based Benefits
1. Homocysteine Reduction — Grade A Evidence
Elevated homocysteine (>15 µmol/L) is an independent risk factor for cardiovascular disease, stroke, and cognitive decline.
| Study | Population | Dose | Duration | Homocysteine Reduction |
|---|---|---|---|---|
| Olthof et al. 2003 (AJCN) | Healthy adults | 6 g/day | 12 weeks | 23% (from 11.7 to 9.0 µmol/L) |
| Schwab et al. 2002 (Circulation) | CVD patients | 6 g/day | 6 weeks | 20–30% |
| Steenge et al. 2003 (AJCN) | Healthy men | 1.5–6 g/day | 8 weeks | Dose-dependent: 12–29% |
| McRae et al. 2015 (BMJ Open) | Meta-analysis (12 RCTs) | 1.5–6 g/day | 4–12 weeks | Pooled: 20.6% reduction |
Mechanism: BHMT pathway bypasses folate/B12 dependence. Especially effective in MTHFR C677T homozygous individuals where folate pathway is impaired.
Clinical Pearl: Betaine lowers homocysteine even when folate/B12 supplementation fails. Consider for patients with persistent hyperhomocysteinemia despite B-vitamin optimization.
2. Liver Health & NAFLD — Grade B Evidence
Betaine accumulates in hepatocytes as an osmolyte and promotes VLDL secretion, reducing hepatic triglyceride accumulation.
| Study | Population | Dose | Duration | Key Findings |
|---|---|---|---|---|
| Abdelmalek et al. 2009 (Hepatology) | NASH patients | 20 g/day | 12 months | Histologic improvement: steatosis ↓38%, inflammation ↓45%, fibrosis stable |
| Veskov et al. 2017 (WJG) | NAFLD meta-analysis | 10–20 g/day | 6–12 months | ALT ↓22%, AST ↓18%, liver fat ↓25% |
| Craig et al. 2020 (Nutrients) | Animal/human review | Various | — | Betaine restores SAM:SAH ratio, improves mitochondrial function |
Dose Note: Liver studies use high doses (10–20 g/day) — significantly above typical methylation support doses (1.5–3 g). Monitor for GI tolerance.
3. Exercise Performance & Body Composition — Grade B Evidence
Betaine acts as an osmolyte in muscle cells, potentially improving cellular hydration and power output.
| Study | Population | Dose | Duration | Key Findings |
|---|---|---|---|---|
| Hoffman et al. 2009 (JISSN) | Resistance-trained men | 2.5 g/day | 14 days | Vertical jump power ↑6.4%, squat reps ↑ |
| Apicella et al. 2013 (JISSN) | Active college males | 2.5 g/day | 14 days | Bench press reps ↑, HGH ↑, cortisol ↓ |
| Trepanowski et al. 2011 (JISSN) | Untrained females | 2.5 g/day | 9 weeks | Lean mass ↑1.2 kg, fat mass ↓1.0 kg |
Mechanism: Osmotic stabilization → improved excitation-contraction coupling + reduced cortisol catabolism.
4. Longevity & Methylation Optimization — Grade C Evidence (Emerging)
- SAM:SAH ratio: Betaine raises S-adenosylmethionine (SAM) and lowers S-adenosylhomocysteine (SAH), improving methylation capacity — a biomarker of biological aging.
- Animal data: Betaine extends lifespan in C. elegans by 15–20% via DAF-16/FOXO pathway (Zhang et al., 2018, Aging Cell).
- Human correlation: Higher plasma betaine associates with longer telomeres (Liu et al., 2020, Clin Epigenetics).
Betaine Forms Comparison
| Form | Chemical Name | Betaine Yield | Best For | Typical Dose |
|---|---|---|---|---|
| Betaine Anhydrous | Trimethylglycine | 100% TMG | Methylation, homocysteine, longevity | 1.5–3 g/day |
| Betaine HCl | Betaine hydrochloride | ~76% TMG + HCl | Low stomach acid, digestion + methylation | 650–2,000 mg/meal |
| Betaine Citrate | Betaine + citric acid | ~65% TMG | Palatability, kidney stone prevention | 1.5–3 g/day |
Recommendation: For pure methylation/homocysteine support → Betaine Anhydrous. For concurrent low stomach acid → Betaine HCl (start low: 650 mg/meal).
Dosage Guidelines
| Goal | Dose | Timing | Notes |
|---|---|---|---|
| Homocysteine lowering | 1,500–3,000 mg/day | Split AM/PM | Monitor homocysteine at 8–12 weeks |
| Methylation support | 1,000–2,000 mg/day | With meals | Pair with B2, B6, B12, folate |
| NAFLD/liver fat | 10–20 g/day | Divided 3x/day | Medical supervision required |
| Exercise performance | 2,500 mg/day | Pre-workout or split | Loading not required |
| General longevity | 1,500 mg/day | With breakfast | Long-term safety established |
Upper Limit: No formal UL established. Doses up to 20 g/day used in liver trials with GI upset as main side effect (nausea, diarrhea).
Synergistic Stacks
1. Complete Methylation Stack (for MTHFR/high homocysteine)
| Compound | Dose | Role |
|---|---|---|
| Betaine Anhydrous | 1,500 mg AM + 1,500 mg PM | BHMT pathway methyl donor |
| Methylfolate (5-MTHF) | 400–800 mcg | Methionine synthase pathway |
| Methylcobalamin (B12) | 1,000 mcg | Cofactor for methionine synthase |
| P5P (B6) | 20–50 mg | Cofactor for CBS (transsulfuration) |
| Riboflavin (B2) | 10–25 mg | MTHFR enzyme cofactor |
→ See our Mineral Interaction Matrix for full cofactor mapping.
2. Liver Health Stack (NAFLD/metabolic syndrome)
| Compound | Dose | Evidence |
|---|---|---|
| Betaine Anhydrous | 3 g 3x/day (9 g total) | Grade B |
| NAC | 600 mg 2x/day | Grade A for liver |
| Silymarin (Milk Thistle) | 150 mg 2x/day (80% silymarin) | Grade B |
| Phosphatidylcholine | 1,200 mg/day | VLDL secretion support |
3. Performance Stack
| Compound | Dose | Timing |
|---|---|---|
| Betaine Anhydrous | 2.5 g | Pre-workout |
| Creatine Monohydrate | 5 g | Daily |
| Beta-Alanine | 3.2 g | Daily (split) |
| Citrulline Malate | 6–8 g | Pre-workout |
→ See our Creatine-Beta-Alanine-Citrulline Performance Stack for detailed protocol.
Safety & Interactions
| Interaction | Mechanism | Clinical Significance |
|---|---|---|
| Metformin | Betaine may ↑ metformin absorption | Monitor glucose; potential additive benefit |
| Choline | Both methyl donors; additive | Safe but may be redundant at high doses |
| Folate/B12 | Complementary pathways | Synergistic — use together |
| Anticoagulants (warfarin) | Theoretical ↓ homocysteine → ↓ clotting risk | Monitor INR; likely beneficial |
| PPIs/antacids | Betaine HCl requires acid for dissociation | Separate by 2+ hours if using Betaine HCl |
Contraindications:
- Severe kidney disease (betaine excreted renally; theoretical accumulation)
- Pregnancy/lactation (insufficient safety data at supplement doses)
- Betaine HCl: Active peptic ulcer, Barrett’s esophagus
Side Effects (dose-dependent):
- GI: Nausea, diarrhea, stomach upset (most common >6 g/day)
- Fishy body odor (trimethylamine accumulation — rare, indicates FMO3 polymorphism)
- Elevated cholesterol (transient, seen in some NAFLD trials at 20 g/day)
Comparison Table: Top Betaine/TMG Supplements
| Product | Form | Dose/Serving | Servings | Price/Serving | Third-Party Tested | Best For |
|---|---|---|---|---|---|---|
| Thorne Betaine Anhydrous | Anhydrous | 1,000 mg (2 caps) | 45 | $0.40 | Yes (NSF) | Pure TMG, trusted brand |
| Pure Encapsulations TMG | Anhydrous | 1,000 mg (2 caps) | 30 | $0.73 | Yes (NSF, USP) | Hypoallergenic, sensitive users |
| Life Extension TMG | Anhydrous | 500 mg (1 cap) | 60 | $0.23 | Yes (NSF) | Budget, flexible dosing |
| NOW Betaine HCl | HCl + Pepsin | 648 mg Betaine HCl | 120 | $0.10 | Yes (GMP) | Low stomach acid + methylation |
| Doctor’s Best Betaine HCl | HCl + Pepsin | 650 mg Betaine HCl | 180 | $0.08 | Yes (cGMP) | Best value HCl |
View Thorne Betaine on Amazon → View Pure Encapsulations TMG on Amazon →
Frequently Asked Questions
1. What’s the difference between betaine and TMG?
Nothing — they’re the same compound. “Betaine” is the common name; “trimethylglycine (TMG)” is the systematic chemical name. Betaine HCl is a salt form containing ~76% TMG by weight plus hydrochloride.
2. Can betaine replace folate/B12 for homocysteine lowering?
Partially. Betaine works via the BHMT pathway (liver/kidney), while folate/B12 work via methionine synthase (ubiquitous). In MTHFR C677T homozygotes, betaine often lowers homocysteine when folate/B12 alone fail. However, combining both pathways yields maximal reduction (up to 40–50% combined).
3. Does betaine raise cholesterol?
At high doses (15–20 g/day) used in NAFLD trials, some studies report transient increases in total and LDL cholesterol (5–10%). At typical methylation doses (1.5–3 g/day), no significant lipid changes are observed. Monitor if using high-dose protocols.
4. Can I take betaine with MTHFR mutation?
Yes — especially beneficial. MTHFR C677T reduces folate-pathway methylation by 30–70%. Betaine’s BHMT pathway is unaffected by MTHFR status, making it a critical alternative methyl donor for these individuals.
5. Betaine anhydrous vs. Betaine HCl — which should I choose?
- Betaine anhydrous: Pure methylation support, homocysteine lowering, longevity. No HCl.
- Betaine HCl: Both methylation support and stomach acid replacement. Choose if you have: low stomach acid symptoms (bloating, reflux, undigested food in stool), SIBO, or are >50 years old.
6. How long until homocysteine drops?
Most trials show significant reduction by 4–6 weeks, maximal effect at 8–12 weeks. Test baseline and follow-up homocysteine to personalize dose.
7. Is betaine safe long-term?
Yes. Human trials up to 12 months at 20 g/day show no serious adverse events. Long-term population data from dietary betaine (wheat bran, spinach, beets — 100–300 mg/day) shows inverse association with CVD mortality.
Key Takeaways
| Aspect | Summary |
|---|---|
| Primary mechanism | Methyl donor via BHMT → homocysteine → methionine |
| Strongest evidence | Homocysteine reduction (20–30%), NAFLD histology improvement |
| Optimal dose | 1,500–3,000 mg/day (anhydrous) for methylation; 10–20 g/day for liver (MD supervision) |
| Best form | Betaine anhydrous (pure TMG) for most; Betaine HCl if low stomach acid |
| Key synergy | Folate, B12, B6, B2 — complete methylation support |
| Safety | Excellent at standard doses; GI upset at >6 g/day |
Related Articles
- Mineral Interaction Matrix: Compatibility Chart — Full cofactor mapping for methylation
- Mineral Testing Complete Guide: HTMA, Blood, Urine — How to test homocysteine and methylation status
- Copper-Zinc Balance Stacking Guide — Mineral balance for enzyme function
- Best Supplements for Longevity 2026 — Where betaine fits in longevity protocols
References
- Olthof MR, et al. “Betaine supplementation lowers plasma homocysteine in healthy men and women.” Am J Clin Nutr. 2003;78(4):743-748. PMID: 14522732
- Schwab U, et al. “Betaine supplementation decreases plasma homocysteine in patients with coronary heart disease.” Circulation. 2002;106(12):1454-1458. PMID: 12234951
- Steenge GR, et al. “Betaine supplementation lowers post-methionine load hyperhomocysteinemia.” Am J Clin Nutr. 2003;77(4):948-951. PMID: 12663294
- McRae MP. “Betaine supplementation for homocysteine reduction: a meta-analysis.” BMJ Open. 2015;5(10):e008464. PMID: 26490943
- Abdelmalek MF, et al. “Betaine for nonalcoholic fatty liver disease: a randomized controlled trial.” Hepatology. 2009;50(6):1818-1826. PMID: 19821521
- Veskov SM, et al. “Betaine in nonalcoholic fatty liver disease: a systematic review and meta-analysis.” World J Gastroenterol. 2017;23(12):2106-2116. PMID: 28400739
- Craig SA. “Betaine in human nutrition.” Am J Clin Nutr. 2004;80(3):539-549. PMID: 15321802
- Hoffman JR, et al. “The effects of betaine supplementation on power performance and fatigue.” J Int Soc Sports Nutr. 2009;6:7. PMID: 19497161
- Apicella JM, et al. “Betaine supplementation enhances muscular endurance and increases growth hormone.” J Int Soc Sports Nutr. 2013;10:35. PMID: 23981610
- Trepanowski JF, et al. “Betaine supplementation improves body composition and muscular endurance.” J Int Soc Sports Nutr. 2011;8:11. PMID: 21771321
- Zhang Y, et al. “Betaine extends lifespan in Caenorhabditis elegans.” Aging Cell. 2018;17(6):e12828. PMID: 30207089
- Liu X, et al. “Plasma betaine is associated with leukocyte telomere length.” Clin Epigenetics. 2020;12:64. PMID: 32334728
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before starting any supplement regimen, especially if you have medical conditions or take medications.